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CHAPTER I 
INTRODUCTION 
AND 
STAT»fENT OF THE PROBLEl'.f 
Investigators in recent years have shown more and more the impor-
tance of enzymes in bodily processes. Receiving equal attention of in-
vestigators are the enzyme inhibitors. Since the beginning of the twen-
tieth century it has been known that an1mal and human sera have an anti-
proteolytic enzyme action. This phenomenon has been investigated in re-
lation to many diseased states, among which are included those with a 
common gro'tll'ld of severe inflammatory a.ctivity or tissue necrosis. The 
importance of certain ensyme activities in inflammation has aJ.so been es-
tablished. Investigations have been performed which show the presence of 
proteolytic eM)'me inhibitors in animal and human tissues. Ultimately, 
it 'tfOuld seem that the proper functioning of bodily processes is greatly 
dependent upon the interrelationship .of enzymes and their inhibitors. 
The purpose of this investigation was to study the activity or pro-
teolytic enz,.es in human gingival tissue under normal and in chroni-
cally inflamed condi tiona in light of the available information regard-
ing proteolytic enzyme inhibitors. 
Since little methodology in respect to this type of investigation is 
present in the literature, the develoJlllent of a workable technic is con-
sidel"6d to be an important part of this study. 
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CHAPl'ER II 
REVIEW <F THE LITERATURE 
Studies of the antiproteolyt1c activity of tissues have been pre-
ceded by the investigation of the antiproteolYtic activity of the serum 
of animals and h'J.II\MII. Thia field of investigation is closely related to 
the problem of this paper and a review o£ the literature of the antipro-
teolytic action of the serum will provide a. fuller understandiJ'!.g of the 
present problem under investigation. 
Hildebrandt (189.3), Camus and Gle,. (1897) and Landsteiner (19OO) have 
been credited bY' other reviewers of the literature for the first observa-
tions of the inbib1 tory power of serum on the action of trypsin. However, 
review of these publications shows that the experimental technic involved 
in these works was primarily the injection of an enzyme, which is protein 
in natur.e, into experimental animals. The reactions observed were inhibl-
tor.r to be sure, but :lUSt be interpreted as an antibody reaction to the 
protein nature of the enz~e. The~e l1orks, therefore, do not demonstrate 
the presence of an enzl'TIe-ant1enzyme reaction with which this paper is con-
cerned as stated in the first chapter. 
Opie (1905) studied the enzy.rnatic ond. LYltienzymatic a.ction of in-
flammatory exudates, by production of experimental inflammatory reactions 
in the peritoneal cavities of experimental ani.m.a1s. By collect.ing the 
leukocytes produced in the inflam'natory procesS and allowing the auto-
lysis of these cells, he determined the proteolytic enzyme activity of 
-2. 
-3-
the leukocytes. Opis was able to demonstrate the inhibitory effect of 
blood sertll1 and inf'lammatory exudates upon the enzyme leukoprotease of 
the leukocytes by incubation of these with the leukocytes. Fram this the 
conclusion was made that serum had the power of inhibiting proteolytic en-
zymes of the leukocytes and that this inhibitor probably passed into the 
exudates of the inflammatory process. In· the later stages of 1.n:fl.amma-
tion there was sane diminution of the antienzymatic action. 
HUssey and Northrop (1922) investigated the antitryptiC activity or 
the blood. They found that the inhibitory agent and trypsin combine to 
form an inactive but dissociable compound. 'rhe reaction in equilibrium 
could be expressed by the equations 
Trypsin + inhibitor ~ trypsin.inhibitor 
These investigators stated that the cornii tiona of equillbrilll'll are govern-
ed by the law of mass action. 
RUnitz and Northrop (1936) developed a method of crystallization of a 
trypsin inhibitor from beef pancreas. The inhibitor also inhibited chymo-
trypsin but to a lesser extent. The inhibitor displqed the general 
properties of a polypeptide. 
~b (1943) studled the nature and e:xperimental variation of the anti .... 
proteolytic activity of serum. by intravenous, intramuscular and oral ad-
ministration of trypsin in rabbits. He fotmd that intramuscular admlnls-
tration of trypsin resulted in a slow rise in the antiproteolytic activity 
of the serum. followed by a lesser decline. Intravenous administration re-
sulted in no anpreciable variation. Oral a.dministration resulted in a 
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rapid rise~ which was sustained during the period of administration. In-
tramuscular~ intravenous and oral administration of denatured tlj'PSin re-
sulted in no appreciable variation. 
Determinations of antiproteolytic activity of the serun were made by 
the degradation of casein and by a proposed experimental formula devised 
by author. From these facts and from the findings of Kunitz and Northrop, 
mentioned above, Grob attached. important Significance to the products of 
protein hydrolysis both in the intestine and parenterally in relation to 
the antiproteolytic activity of the serum. On the basis of the nature and 
magnitude of the experimental variations obtained in his work and on the 
lack of parallelism between precipitin tests performed on the animals and 
antiprotease activity, Grob stated that antibodies to trypsin were not an 
important factor in the antiproteolytic activity of the serum. 
Investigating further the nature of the antiproteolytic substance 
in the serum, Grob (1945-46) presented evidence that leukoprotease and 
trypsin are inhibited by reducing agents, including thiol-sulfhydryl com-
pounds and ascorbic acid. It was shown that the antiproteolytic activity 
was largely confined to the albumin fraction of sel"llrl. According to Grab 
the inhibitory factor was not diaJ.ysable. fhe reported fact that the anti-
proteolytic factor was not freely diffusible in the body except when in-
flammatory or other pathologic processes increase capillary permeability, 
is in agreement with the conclusion of Opie. 
Dutherie and Laurenz (1949) supported the findings that the serum. 
antiprotease is associated with all the serum protein fractions but main-
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ly 'tnth the most soluble albumin fraction. They also found that the serum. 
trypsin inhibitor v..'"S.S relatively stable but was sensitive to the lowering 
of pH, which is in agreement with the findings of' Grob (1945). Dutherie 
and Lorenz were unable to reproduce the results of Grob concerning the 
variations of the antitryptic levels of serum, by the administration of 
trypsin. In their studies there was only a 15% increase in the anti-
trypsin activityof' serum after four weeks of subcutaneous administration 
in rabbits. No incres.se ~ras observed after oral administration. 
Rusk and Cllffton (195.1) investigated the relationship of the anti-
proteolytic activity of serum with the fibrinolytic activity. ».r in-
jecting 80ybean trypsin inhibitor of Kunitz and Northrop intravenously in .. 
to mice they were able to increase the antitryptic activity of the serum. 
The changes were observed for a. week or longer following the injections, 
indicating the slow destruction or excretion of the so,Ybean inhibitor in 
Vivo. 
The relation of a polypeptide structure to the antiproteolytic fae-
tor in serum has been reported often in the literature. Ungar and Adler 
(1956) have reported the discovery of a peptidase in guinea pig serum 
whose activity closely parallels the guinea pig serum protease inhibition. 
The action of the peptidase is detectable by its action on a chranogenic 
substrate glycyl-beta-naphthyla'line. Competitive inhibition of the pep-
tidase action by both plasmin and trypsin suggested that the proteases 
were substrates for the peptidase and. that the antiproteolytic activity 
of guinea pig serum 'Was due, at least in part, to the enzymatic destruc-
tion of proteases. "fuile this phenanenon was found to be present in 
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other species including man, its relationship to 'protease inhibitiOn was 
not as marked. 
In discussing proteolytic enzyme inhibitors John Bodman (1958) 
specifies the presence of two separate inhibitors for trypsin and chymo-
tryps in. According to Bodman both could be separated by curtain electro-
phoresis. The trjlpSin inhibitor appeared in several fractions and the 
chymotrypsin "las always collected in the fraction between the oc..l glob-
ulins and the albumin. Bodman suggested that the serum inhibitor titers 
might poss :Lbly be under hormonal control. 
Aizana (1960) conducted zone electrophoresis studies to determine the 
relationship of tl7'PSin and chymotrypsin inhibitors to each other. Using 
a newly developed zone electrophoresis technic it was determined that the 
grea.t~r part of both trypsin and ch)'motr)'psin inhibitors migrated with the 
alpha globulin fraction. Sane inhibitory a.ctivity was found with the 
cc2 globulin. Studies of the pathological. sera showed the same distribu-
tion of the inhibitors in the q 1 globulin. The ratio of inhib:i.tor,y 
activity between trypsin and chymotrypsin inhibitors in noma! am patho-
logical sera did not var:! significantly. As a result of these findings 
it .. raa concluded that the inhibitory activity against trypsin and chymo-
trypsin lTas exerted by a single inhibitory substance. 
Vermeenko (1960) .found that serum and plasma inhibited trypsin ac-
tivity to the same degree and whole blood was 30% less inhibitory. When 
casein ~ras used as a. substrate, the trypsin activity inhibition depended 
upon the amount of plasma. The add! tion of urea to casein substrate caused 
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a marked deviation £rom the linear dependence. Curves representing tryp-
sin activity dependence pointed to the dissociation of the trypsin in-
hibitor complex. The effect of urea on the complex dissociation indic-
ated the involvement of H bonds in the mechanism of the trypsin inhibitor 
complex. The dependence of the dissociation of the trypsin inhibitor 
cc:mplex on the nature of the substrate shol,Ted th.:'l.t the substrates were 
capable of competing with the inhibitor for the free ~JPBin. A dynamic 
equilibrium established itself between the trypsin and the inhibitor on 
the one hand and the substrate on the other. 
Thus far the presence of an antiproteolytic factor in the serum has 
been eeta.blished tmd a beginning insight into its nature has been discus-
sed. However, the problem of this "l'ork concerns the presence of a pro-
teolytic enzyme inhibitor in tissue. Opis (1905) discusses the possibU-
ity ot the passage of the serum inhibitors into tissues in inflammatory 
exudates. This possibility has been confirmed in the literature. HmoJ-
ever I the investigations of a tissue inhibitor have been tmderlaken only 
recently and to a limited extent. 
Astrup (1952) described a potent fibrinolytic inhibitor in ox lung 
tissue " .. bieh appeared to be an antiproteolytic substance. 
Scevola, Calchi, 1'1ovati, and Felisati (1954) and Scevola a.."1d Felisatl 
(1955) investigated human, rabbit, guinea pig and ox tissues which in-
cluded lung, heart, liver, kidney, muscle, stomach, uterus and placenta. 
The studies vlere done on h('W,\ogenates of these tissues. Trypsin inhibi-
tion varied between tissues of the same animal and between species for 
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the identical tissue. upon 20 minute contact trypsin inhibition by lung 
was 90, 78, 35, 29 and 28% in ox, guinea pig, humans, rat and rabbit re-
spectively. The inhibition for heart tissue was 50, 42, 38, 34, and 11% 
for guinea pig, rat, ox, rabbit and humans; for pla.centa 67, 63, 26, 18 
and 11% for humans, guinea pig, ox, rat, and rabbit respectively. Guinea 
pig uterltil showed maJd.m.um inhibition; lowinhit)ition was shown for muscle, 
stomach, kidney and liver tissues. In general, chymotrypsin was inhibit-
ed much less than trypsin. Human tumoral tissue shcr<iOO an irregular be-
havior. The antit%7Ptic activity was sometimes lower, as in lung, and 
sometimes higher, as in brain, than in nonnal tissue. 
Astrup and Stage (1956) isolated and partially purified a protease 
inhibitor from ox lung tissue. The active caupound had a characteristic 
themostability and was most stable at acid reaction and "TaB destroyed at 
neutral and alkaline reaction. These pH reactions are the reverse of 
those of the serum antiproteolytic factor reported this far. 
By subjecting tissue monocytes in a culture to an antigen-a.'"ltibody 
reaction, Tokuda (1959) studied the proteolytic mechanism of the antigen 
antibody reaction. Sensitized rabbit monocytes were subjected to an anti-
gen-antibody reaction in a specially designed culture chamber and were 
found to release a protease into the culture fluid. Begin!1ing at 24 hours 
and up to 48 hours a proteolytic inhibitor was released. Evidence was 
given that the inhibitor "Tas definitely of cellular origin. The protease 
L~~ibitor was isolated and partially purified and found to also inhibit 
the protease of euglobL, fractions prepared from the area of arthus-like 
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b;ypersensitivity and papain but not of trypsin. It was pointed out that 
both of these protease. had. an essential SH group. '!'he inhibitor also 
gave a slight Biuret reaction indicating that it might have been a poly-
peptide. Although this study was essentially concerned 'r;rith t.he antigen-
antibody reaction of cells, viewed in the light of resronBf's to ce1J. 'llar 
injury, it 113 particularl,'V interesting and me-y he reJ.e,ted. to the prohlem 
studied in this paper. 
The relationship of the antiproteolytic activity of the serum and 
various disease states has been conf'imed in the literature. One of the 
earliest worl~, that of Opie (1905), implic~terl the antiproteol~~ic fac-
tor l-l'ith the inflam.."!latery process. Rm-rever, one of the earliest investi-
gs,tiona correla.ting the antiproteolyt.ic activity of serum and the ir'..f.lam.-
matory process was thet of Hert (1909). He not~d that the inhibitory 
ael'tlll levels were elevated in all the C8Ses of ir..fecM.ous dis€,ascs 8tudied. 
The levels remained elevated through the ~0urse of infection until conv~­
lescence had been fully established. Antitryptic levE>ls of serum -:-mre also 
elevated in pathologica~ eases involving cellular destruction lilich were 
not of infectious·causes. 
An. ex.amination of 2,000 cases by l-lest and Hil1iatVI (1949) indicated 
a relationship of proteolytic enzyme inhibition, specifically e~otr:Y'ps1n 
~"'1d ren.'1in, to numernu.s disease states. In this study acut~ i'1f~ctious 
conditions, influencing chymotrypsin inl'l.ibitors pre<iomirumtly, eO!'1:prised 
24% or all of the cases studied. 
The 'T/ork of Dillard and Chanutin (1949) established some facts :1hich 
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should be kept in mind. This work studied serl,.w levels of proteolysin, 
plasmin, and trypsin inhibitor of plasma. in cancer patients and a variety 
of acute and chronic disease states. No relationship be1ilreen all of these 
"''38 evident in tha study. However, both proteolysin and trypsin inhihitor 
could be related to cancer and to acute infectious disease statt~S afJ 
evidenced by increased serlU11 level. The trypsin inhibitor concentration 
level remainr-d eleva.ted in those 11ho had been operated on and in those 
whose tissues t·1ere tmdergoing readjustment to the normal state. 
'1'a,uber (1950) found thl'l.t of cases exemined 8.1% of those with acute 
1n:f'ections shmrod abnormal tests of chymotrypsin inh1bition. E:tght and 
~10 tenths per cent of those ",.nth chronic infections shwed cbnol"rM.1 levels. 
CHA.P1'ER III 
MATmIALS AND ME.THODS 
Th1a study 'Was performed upon sixteen subjects of whOtll nine oerved 
as a control group and seven as an experimental group. It was decided 
to limit the study to male subjects in an age range from 25 to 35 years. 
'l'his vms done to eliminate as much as possible variations result,ing fran 
sex differences and variations vyhich might be attributable to aging pro-
cesses. rhe medical histories of both the control and the experiment6.l. 
subjects revealed no recent systemic diseases of consequence. The con-
trol subjects were apparently healthy at the time of the study. The ex-
perimental subjects 'ti'eTe healthy aside from the periodontal disease. 
'!'he tiBsue studied "Tas the attached gingiva. Tissue specimens were 
obtained from the vestibular and tnter-dental aspects of the pre-molar or 
anterior teeth of either the maxilla or mandible. The decision as to 
'f.:'bieh area was to be biopsied was based upon clinical diagnosis. The 
areas biopsied in the subjects of the control or normal group shaw cli11-
iCl;' 1y normal gingival tissues. The areas taken from the subjects in the 
experimental group showed chronic inflam.ma.t.ion. An histological specimen, 
stained 1Tith hE'matoxylin and eosin, lias made of €ach tissue sample to con-
firm the clinical diagnosis of -the state of the tissue. 
Orban periodontal knives were used to excise the tissue specimens. 
Anesthesia w~s obtain~l through infiltration of procaine t~ochloride 
anesthetic ldth epinephrine 1:50,000 concentration. The injection was 
made e.s far removed as possible from the sight of the operation. The 
-11 .. 
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specimen was 1-Tuhed in tap water and blotted dry'. At this time a portion 
was removed. from this specimen, fixed in 10% foma1in and prepared for 
histologic examination as mentioned above. The histological diagnosis 
ot the state of the tissue was determined by an histologist other than the 
present invest~ator. The greater portion ot the specimen was placed into 
a Petri dish, covered and placed in a freezer cmpartment at about -20 de-
greed Centigrade. Proteolytic activity- of the specimen was determined 
within the next twenty-tour hours as will be described he10101. In most 
instances, a sample of venous blood was also obtained in order to assess 
the proteolytic behavior of the serum associated with the ICI'ing1val s"Oecimens. 
!'he Method of Bodman (19$7) for the measurement of the proteolytic 
enzyme inhibitor of serum was adapted to this study. The principle in-
'Vo1ved in this method is to establish an enzyme,substrate model ot mown 
concentration and reaction rate. '!'his model served as a control. To 
detemine whether tissue contained substances which arfect the rate of this 
enzj'!llic acti'Vity, an homogeniSled tissue specimen of mown weight and con-
centration was allowed to incubate in contact with the determined amoutrli 
of enz:vme tor a gi'Wm period of time. This modified enzyme wes then in-
corporated into an enzyme • subs trate model. The amount of hydrolysis ot 
the subs trate by- the enzyme was determined tor both the control model 8l'ld 
the e:x:perimental model whose enzyme constituent had been allowed to be 
in contact with the homogenized tissue before acting upon the substrate. 
Reagents for an enzyme.substrate model were prepared in the follow-
ing manner. Eight mg. of vitamin tree test casein code nunber CMX-1l55 
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contributed by Abbott Laboratories were added to 180 ml. of distilled 
water with 6.0 ml. of lJl sodium hydroxide. '!'his was shaken in a stop-
pered wide-mouth fiask twenty times and allowed to stand for one hour at 
l"OCIIl tempe1"'ature. '1'0 this emulsion was added 284 111. of distilled water, 
a crystal of thymol and a few drops of octyl alcohol. !his solution is 
both the substrate and the buffe of the syst_. The final pH is 7.6. 
The eM3'lle used for this st'lldy was c~otrypsin. Chymotrypsin wu 
chosen as the proteolytic enzp!e hecause of the available knowledge about 
it and because of the reliabUity of its reaction. Seventy mg. of Cl78-
tallized ch1motrypain (1075 Armour lib un1ts/mgm.) contributed by Armour 
Pharmaceutical Company were diluted in 250 ml. of 0.002 K bydrochloric 
acid. '!'hen 65.3 ml. of this enzyme solution were diluted to 100 ml. with 
0.002 M hydrochloric acid. This was temed the stock enzyme solution. 
It could also be prepared by' weighing 18.3 mgm. of ch)1motr,psin and di-
luting it to 100 ml. with 0.002 K ~hloric acid. a,drolywis studies 
of the chymotrypsin with casein dem.Oll8trated that further dilution of the 
stock enz,me solution was necessary in this studT, because of the great 
activit,. of the eMp!e supplied to us. A ten-fold dilution was decided 
upon. It was prepared b,. dUuting 1 ml. of stock enzyme solution to 10 
Ill. with 0.002 K hydrochloric acid. This was then called the world.ng 
enzyme solution. Hydrolysis rates were determined and hydrolysis curves 
were plotted. From these the ~Isubstrate model eoncentratiOll8 used 
in this study were determined. Aliquots of the standard enzyme and work-
ing enz,.e were made according to the protocol shown in Table I. Each 
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TABLE I 
CHlMOTRYPSIN HYDROLYSIS STUDY 
TABLE I 
INCUBATE 2 HOURS AT 380 C. 
MIX LET STAND SHAKE INCUBATE 
% TRANSMISSION 
iClmrRlFUGE DECAN'!' 
Tube Enzyme HCL Saline Casein TCA 10% Digest NaOH CuS04 Trial 1 Trial 2 
1 5.0 2 .. 5 2.,5 15 3 5 1 1 12.0 9.0 
2 2.5 5.0 2.5 15 3 5 1 1 14.5 12.0 
PIPETTE 
3 1.0 6.5 2.5 15 3 5 1 1 17.0 18.5 
1 : 10 
4 7.5 0 2.5 15 3 5 1 1 20.5 21.5 
5 ml. 
5 5.0 2.5 2.5 15 3 5 1 1 24.0 25.8 
6 2.5 5..0 2.5 15 3 5 1 1 32.0 32.0 
SUPER-
7' 1.0 6.5 2.5 15 3 5 1 1 47.0 48.5 
NATANT 
8 0 7.5 2.5 15 3 5 1 1 83.0 86.0 
1:---- HYDROLYSIS -----t +-STOP R!ACTION--i ~--' -- BIURET REACTION ------i 
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aliquot was made up to 10 ml. 'Vo1ume as shown. Fifteen DIl. of casein 
solution, prepared as described. abO"1e, were added to eaoh test tube. 
'- These tubes 'W'el"e then placed in a water bath at 38 degrees Centigrade for 
two hot1l'8. 
The degree of hydrolysis was determined by measuring the quantity of 
protein ~olys1a products produced. A set of ser1ally' nlJlbered tubes, 
eaoh containiDg .3 ml. ot 10% trichloracetic acid was prepared. Fift ml. 
of the contenta of the respeotive tubes oontaining the digestion mixture 
were added to the prepared tr1cbloracetic acid-eonta1n1ng tubes. The 
tubes were mixed b:r inversion and allowed to stand at rOClll temperature for 
10 minutes. Th1a procedure stopped the hydrolysis reaction of the enzl'Dle 
and substrate. The tubes were then centrifuged at 3,500 r.p ... for 20 
minutes. !.he supernatant was pipetted into another set of identically' 
nUllbered tubes. The products of hydrol:ysis were then measured by the 
huret method. 
The V1chloracetic acid soluble material in the supernatant liquid 
represented the products of hydrol)'sis. The percentage of trichloracetic 
acid that is used in this procedure is critical. The trichloracetic acid 
soluble material consists of polypeptide chains of a particular molecul.ar 
weight whicb are the result ot ch;ymotrypsin action upon the protein, casein. 
Greater concentrations of triohloracetic acid would preoipitate not onl7 
whole protein moleoules not yet digested but alao a portion of the poly-
peptide chains as well. Lesser ooncentrations of trichloracetic acid 
would tail to preoipitate intact molecules ot polypeptides. Therefore, 
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variations in the trichloracetic acid concentrations would intluenee sub-
nquent analysis of the supernatant liClUid. 
The supernatant liquid vas prepared for the Biuret reactionby' pi-
petting as much of the supernatant as possible into correspondingly n'\IU-
bered. tubes containing 1 JIll. of 30% Sodi. hydroxide. To these tubes 1 
JIll. of S% wiT copper sulphate was added and the tubes were shaken to break 
up the gel which fOl'lled. The tubes were then placed into a water bath at 
38 degrees Centigrade for 10 ~ after which they were again centrif-
uged for 10 ndnutell at 3,,00 r.p... The Biuret color thus developed. was 
measured b,. means o£ a Coleman Junior spectrophotaaeter. The fUter wu 
set at 60" ~'. The results were recorded in % transmisSion and were 
charted on graph paper. 
rIle reaul t1ng graphs are shown in figures 1 and 2. From th1B the 
concentrations for the enzl'Measubstrate model were determined and set at 
2., ml. of the so-called working ensyme solution and 15 ml. of casein 
prepared as described above. 
Sample tissue specimens obtained in the manner described above and 
stored at -20 degl"ee8 Centigrade were used to dete1"!ll1ne the proper concen-
tration of the t.isaue homogenate to be used. The tissue was weighed on 
an accurate laboratory balance to the nearest tenth of a mill1gra. 
'!'he tissue was then homogenized in a Potter homogenizer, the pestle be-
ing fitted by a friction clutch to an electric motor. '!'he hanogentzer 
was subnerged in a melting iee vater bath during the entire time of hOlla-
genation. The trial specbnens weighed 54.5 mg. and 61.9 mg. These 
+- +-r- -i- - - - ---L+- -t- - --r f- ---t- -- - - -- r- ---+-l--l--+-+--+---1 
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were"homogenized in 15 ml. and 17 ml. of saline solution in order to have 
identical concentrations. A,liquots of the tissue homogenates were made 
as shown in Table II. Two and one-half ml. of the working enz,m,e were 
added to each of the aliquots and allowed to stand at roam tempfl'.rature for 
twenty minutes. Each tube was llI-~itated once each minute. Fifteen ml. of 
casein were then added to each aliquot and the tubes were incuba.ted for 
two hours at ,38 degrees Centigrade. Each tube was agitated every five min ... 
utes. The reaction was then stopped by the addition of ,3 ml.. of 10% tri-
chloracetic acid. The sample was prepared for the Biuret reaction as 
described above. The protocol for this procedure and the spectrophoto-
1Ieter readings are shown in Table II. 
On the basis of these data it wa.s decided that, it any inhibiting 
1'actor or proteolytic factor was present in the tissue, it must be pre-
sent in low concentration. It was decided, therefore, to reduce the con-
centrations of the reagents by a factor of five. In this ~ the relative 
concentration of the tissue homogenate could be increased 'While using a 
biopsy specimen within reasonable size. The tissuelsaline ratio for the 
preparation of the h<ll'1ogenate was set at 37 mgJIl. of tisauel 2 ml. of 
saline. Table m illustrates the protocol by which the protease ac-
tivity of the tissue specimens was measured. The results of' the Biuret 
reaction were again recorded as % transmission ~ means of a Coleman 
Junior spectrophotometer using a 605 A filter. These readings were then 
transcribed to optical density to facilitate statistical analysis. 
Since pathological specimens were obtained from patients undergoing 
TABLE II 
TISSUE HOMOGENATE DETERMINATION 
TABIE III 
EXPERIMENT AL PROTOCOL 
TABLE II 
IN~TE MIX !SHAKE INCUBATE 
LET STAND 20 MIN. SHAXE 38 C LET STAND CENTRIFUGE % TRANSMISSION 
SHAKE CENTRIFUGE WCANT 
Homo- WOrking 
Tube saliDe Casein TCA 10% Digest NaOH CUS04 Trial 1 Trial 2 I Il8nate 1 2 IDDma 
, 
1 5 0 2.5 2.5 15 3 5 1 1 26.5 31..0 
PIP":TTE 
2 4 1 3.5 2.5 15 3 5 1 1 28..2 38.0 
5 MI. I 
3 J 2 4.5 2.5 15 3 5 1 1 28.2 32.0 
SUPER-
4 2 J 5.5 2.5 15 3 5 1 1 28.8 32.5 
NATANT 
5 0 5 7.5 2.5 15 3 5 1 1 28.0 32.5 
6 0 7.5 10.0 0 15 3 5 1 1 84.0 J 
I 
'I'MlLE III 
IN~TE MIX SHAKE INCUBATE 
L!'l' S'l'dD 20 MIl. SHAXE 38 C LET STAND CENTRIFUGE % 'l'RAlfSMISSIOR . 
SHAKE CEN'l'RIl'UGE DECANT I 
BolIO- WOrking ! 
'I'IIbe SIllDe Casein TCA 10% Digest lfaOH CuS04 
DJlAte 1!:Ds~ 
! 
I 
Spec1Mn 1 0.5 0 .. 5 3.0 3 5 1 1 I 
PIPETTE 
Coatro1 0 1 .. 5 0 .. 5 3.0 3 5 5 Ml.. 1 1 
SUPER-
Blu1t 0 2.0 0 3.0 3 5 1 1 
NATANT 
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periodontal treatment, it was possible to obtain larger tissue speci-
mens. Therefore, it was decided to prepare two saJ'l'q)les fran each patho-
logic speci~en. One was set at the concentration designated in the pre-
ceding paragraph and the other was made at approximately two times as 
great a concentration. Thus the tissue:saline ratio of the homogenate 
... ms about 75 mgm. of tissuet2 ml. of saline. Results were recorded as 
mentioned above. 
Following preliminary exa:nination of these results, additional normal. 
speciJUens were treated in the same msmer as described for the patholog-
ical specimens. In order to make it possible to obtain sufficient tissue 
for two samples of each nomal spec1Jnen, the reagent concentrations were 
reduced by a. factor of two. Thus the necessary tissue homogenate concen-
trations were made possible with a biopsy specimen of reasonable size. 
Since the amount of the final solutions was reduced, it was necessary to 
use a microcuvette with the spectrophotometer to record the results. 
Because two different size cuvettes were ultimately used in this 
study, it was necessary to establish a cuvette factor. This was accom-
p11shed by subjecting the established enzymefsubstrate lnode1 to the pro-
cedure described. The quantity of protein hydrolYSis products produced 
't.rere measured in both types of cuvettes and recorded as % transmission. 
These results "'Yere converted to optical density. From these data a 
cuvette factor of 1.99 was calculated. This then enabled this inves-
tiga.tor to correlate the spectrophotometric readings obtained with the 
microcuvette with those obtained with the larger cuvettea used in the 
major portion of this stuq,. 
CHAPl'ER IV 
FINDImS AND STATISTICAL 
ANALYSIS 
The resu1ts of the e)::perimental procedure descr1.bed above have been 
separated into five groups. The spectrophotometric readings l;ere con-
verted into units of activity by multiplying each reading by 100. The 
data 'Here statistically analyzed. The data of group I are shmm in Table 
IV and the data of groups II, III, IV and V are shown in Table V. 
Group I consists of the results of the hydrolYS~ of the control 
enzyme: substrate models. As can be seen from Table III, a control model 
was included each time that an experimental speciJnen ,.:as analyzed. The 
surr~ation of these individual control models provided the control group 
f or the experiment. A total of sixteen control models were used in the 
experiment and the resulting figures were grouped in a range frau. 2.3.66 
activity units to 56.07 activity units. upon examination of these figures 
in chronological order as can be seen from Table IV, it v-ras evident that 
after subject 15 a sharp reduction in the amount of h~lirolytic activity 
occurred. This 1:,3.5 been attributed by this investigator to a reduction 
in the activity of the enzyme 'tvhich 'Was used in this study. A period of 
about t'tm months had elapsed from the beginning of e,~erimentation to 
that noint. After that time the activity of the enzyme was more constant. 
Si."lce the change in enzyme activity l-1ould have the same effect as an al-
teration in enzyme concentration in the control models, a correction fac-
tor 'Has deternined. The control models of subjects fIl to #5 were averaged. 
-22 ... 
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TABLE IV 
CHOONOLOOICAL ORDER OF EXPERIMENTAL DATA 
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TABLE IV 
CLINICAL RIS'l'OLOGIC mrITS OF ACTIVITY 
SUBJ!'.CT WEIGHT 
mg. EVALUATION BVALUATION CONTROL BLANK HCI40GENATE 
&)50.72 
111 36.9 n01'll8l norsal 50..86 6 .. 70 b)45..84 (1)· 
.)48.81 
12 70.7 normal normal " (2) " b)44.:37 
56.07 8.62 
13 33.2 normal normal 49.49 (3) 9.69 53.31 
14 29.3 normal normal " " 53.46 
115 30.9 normal normal " n 53.76 
32.79 
116 27.6 normal normal 31.43 4.58 32.79 
a):31.88 ,., 69.4 perIodontitis chronic 33.-72 7.57 b)33.72 
Inf'lammation 
.)33.72 
18 49.7 " " 
n 
" b) 35..65 
23.66 7.47 
19 26.8 " " 32.79 7.06 42.02 
a) 3O.J.0 
1110 73.6 
" " 
29.16 8.36 b)27.57 
1111 43.,3 
" " 
28.4£) 8.62 35.65 
37.68 7.57 
112 30.2 
" " 
32.79 6.05 37.68 
26.61 7.20 
1113 (4) 21.1 normal normal 27.80 9.11 27.80 
25.97 
25.97 
1114 23.7 normal normal n " 28.40 
1115 22.8 nOI'JIIBl normal 
" " 
29.59 
(1) ! This Indicates that two samples of homogenate solutIon were treated Ind1v1d 
ually and the readings recorded. 
(2) This indicates that the preceding control and blank were used in the ana-
lysis of data of two or more specimens analyzed on the same da~ 
(3) This indicates that more than one control and blank were analyzed with 
(4) 
• partIcular group of subjects. 
This subject and following subjects were analyzed by a microcuvette method 
( and the data is corrected for the determined cuvette factor. 
TABLE V 
GROUPED EIPiRIMENT At DAT}I. 
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'fABLE V 
GROUP II NORMAL SPECIMENS GROUP III PATHOLOGIC SPECIMENS 
UJlfITS OF ACTIVITY UJlfITS OF ACTIVITY 
SUBJECT WEIGHT SUBJECT WEIGHT 
QONTB~ H~ENATE CONTROL POMOGP 
2:70· 31..8 
11 36.9 26.76· 24.J.3* 
'" 
69.4 33.,72 33.72 
23.35· 33.72 
112 70.7 " 25 .. 69· 118 49 •. 7 " 35.65 
29.·51· 23.66 
113 33.2 26.05* 28.06* 119 26.8 32.79 42.02 
30.10 
14 29.3 
" 
28.J.4* #10 73.6 29.J.6 27 .. 57 
15 30 •. 9 " 28.30· 1/11 43.3 !8.40 35.65 
32.79 37 .. 68 
16 27.6 31..43 32 .. 79 #12 30..2 32 .. 79 37.68 
26.61 
#13 21.J. 27..80 27.80 
25.97 
25.97 
1114 23 .. 7 " 28..40 
1115 22..8 n 29 .. 59 
*corrected for decrease in enzyme 
GROUP V PATHOLOGIC SPECIMENS activitl 
UNITS OF ACTIVITY 
GROUP tv NORMAL SPECIMENS SUBJECT WEIGH'l'·· CONTROL HOMOGENATE 
UNITS OF ACTIVITY 2.3.66 
SUBJECT WEIGw:r-* 119 U.4 32.79 28.40 
CONTROL 
26.61 
POMOGENATE 
#13 30.0 27.80 20 .. 38 1110 137.4 29.16 13.67 
25.97 
25 .. 97 
114 36.2 
" 
20 .. 38 #11 77.8 28..40 24.36 
37.68 
1.l.5 32.7 
" 21.47 1112 46.8 32.79 18 .. 71 .. ' 
The concentration of the homogenate solution vas increased by a factor of 
two by adjustment of the tissue weight and the saline solution. 
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the control models of subjects 116 to IllS were averaged. The controls 
which't:ere obta1ned during the period of greater eIl2yJ1e activity were re-
duced by a factor of 1.9 l1hich teras obtained by dividing these averages. 
The '·'ean for the entire group of control mod,els af"ter this correction 'Has 
29.44 units of activity. The median was 28.78 unite of' activity. The 
standard devte,tion for a small sample (Sx) was found to be 4.27 units of 
activit,". '!'he standa.rd error of the mean ( S.E.-i) for the control group 
was 1.07 units of activity. 
Specimens from normal gingiva which were ana17zed at the hOOlogenate 
concentration of 37 mg. of tissue to 2 ml. of sallne were included in 
Oroup II. A total of nine specimens varied in a range from 24.52 activ-
ity units to 32.79 activity units with a mean activity of 28.11 activity 
units. When each specimen was compared to its related control model, 
little difference could be noted between the two. Seven of the group 
shawed a slight intr1nsic proteolytic activit.y. 7h1s was indicated by the 
fact that the nuaber of activity units was higher for the specimen than 
for the control. 'l\ro specimens exhibited a slight inhibitory action in 
respect to their individual controls as evidenced by lcn-Jer activity read-
ings. fhooup n normal spec:ilJlens had a. median of 28.14 activity 1.mits. 
!he standard deviation (Sx) was 2.58 units. The standard error of the 
mean ( S.E-i ) was 0.79 units. The slight inhibitory activity, which is 
indicated by a comperl,s on of' the means of group I and gr()Up II, is not 
statistically ai.gnificant. '!'his was determined by the a:r;plication of the 
t test to these data. The results of the teat being t23 .. 1.000 which, 
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when applied to probabUity can be expressed as o.h <: P < 0 • .3. In th1s 
instance, a difference as large or greater would occur by chance between 
three and four times out of ten. The clinical eValuation of normal gin-
giva was substantiated by histological section in each case. 
Seven gingival specimens which clinically and histologically' ex-
hibited l:1 ehrcnic inflmwtatory condition and whose tissue homogenate con-
centration ~ '7 rug. of tissue to 2 ru. saline were plaoed into group nI. 
or these specimens one was eliminated from the f'1n.a1 analysis If'..aving a 
total of six specimens. The single specimen was discarded because of the 
m.rer.1e behavior of the tissue homogenate upon the enzymelsubstrate mix-
ture and of the respective control models. Uke the normal spec1mellfl dis-
cl1Ssed above each pa.thologic specimen 't1Y cloeely related to its respec-
t'-",e cnntrol. Four of the specimens showed an intrinsic proteolytic ac-
tivityand two of the specimens had an inhibitory effect. fIm..rever, dis-
similarities were wmifest when the group l-1t:lS considered i.n its entirety. 
{lpoup III had a mean of 35.28 units of ~1ctivity and a median of .35.17 
units of a.ctivity. '!'he standard. deviation lUIS 5.26 units. The standard 
error of the mean ( S. E-i ) was 1.91 un1 ts of act! vi ty. The variance 
between group III and group I has befn shawn to be statistically sign1.i'-
icant by means of the t test. Results of this test show t20 .. 2.666. 
In respect ttl probability this ca.."1 be expressed as 0.02 <:. P < 0.01. 
'fheref'ore, the probability that a difference as great or grea.ter would. 
oceur by chance is between one and two times in a hundred. 
~~en grour. II a~ ~oup III were compared, they were also fo~~ to 
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differ significantly. When the t test was applied, a result of tu .. 3.463 
was obtained. The probability was shown to be 0.01 < P < 0.001 •. A differ-
ence of this ma.gnitude then would oceur by chance only between one in one 
hundred times and one in one thousand times. 
Group IV was CQIIlPrised of three specimens which were taken from sub-
jects who were included in group II. These specimens .:for group IV were 
actually a part of the original biopsy sample .trom a. subject in group II. 
'!'he g1n~i.a1 tissue was histologically and clinically nom.al. The tis-
sue hom~enate enncentration, however, was increased two-fold. i!6.ch of' 
the three aamp1. treated in this maDl'ler exhibited a. decrease in enzy-
matic a.ctivit,. in respect not only to its control model but especialJ .. y to 
its "mate" in group II. This we.a signified by a decrease in the number of 
Q,ctiv1ty unite observed. '!'he mean of this group was 20.74 units of ac-
tivit,-. The median was 20.38 units. The standard deviation ( Sx ) was 
0.88 mite of activity and the standard error of 'the mean (S.E.i) was 
0.51 units of activity. Although group IV was of a very small sample, the 
probability that groups II and IV were of separate universes, was statiB-
tieal.ly greater than 0.001. Onl:r in one in one thousand times would this 
magnitude of difference occur by chance. 
Fach ot the tour specimens in group V wae ala 0 taken from a particular 
subject already- included in group III. The specimens were of chronically 
1nf'1amed gwiva. The only variation again 'WaS a two-fold increase in 
the tisaue homogenate concentration. The mean of 21.19 units of activity 
dUtered greatly trom the mean of group nI which was 35.28 un1t..s of 
activitYe The standard deviation was 0.72 units and the standard error 
of the mean was 0.51 uni tel of activit,.. The variation b~tveen these two 
groupe was statistically sign1ticant as illustrated by the results of the 
t test. For a value of the relative deviate ( sIx ) equal to 3.522 t8 
was shown to be 0.01 < P < 0.001. Therefore, a difterence as great or 
greater would occur by chance between one in one hundred and one in one 
th01ll!land times. 
Groups IV and V were also analyzed statistically for their relation-
ship to each other. Differences between them were found not to be sig-
n1ticant. The value ot the relative deviate was 0.1264. When this is 
applied to the t test tor five degrees ot freed<lJl, the probabil1t;r of 
this occurring by chance 18 greater than nine tau out of ten. 
CHlPrER " 
DISCmSIOI 
Turning for a m(lllent to the first chapter of this report, it w1l1 be 
remembered that an important aspect of this study was the develoJDent o:t 
a method of investigation. !he protocol described in Chapter III illus-
trates a method which has proven to be feasible for measuring proteolytic 
enzym. activity or proteolytic enzyme inhibitor activity in gingival tis-
sues. The usefulness of the method to measure proteolytic activity wu 
shown by the resulta of group III. The abillt)" to detect proteolytic en-
.,.e inhibition was evident in groups IV and V. The results of the con-
trol group, group I, were obtained through the application of methods de-
scribed in the literature and by means of studies of ~ro1ysis or casein 
by c~otrypsin. The latter were performed b)" accepted procedures. Sig-
nificant d1.fferences were obtained between group I and groups III, IV, 
and V in which the tissue hOllogenates were the onl.T variants. 
Once again, let us classify the five groups of data. Group I con-
sists of the results of the bJrdrol.ysis of the control enzymet substrate 
models. The constituents or the control models are shawn in Table III. 
'!'he results or the effect of tissue homogenates of normal gingival speci-
mens upon an ens)'Jlle I substrate model were included in Oroup II. The 
homogenate concentration of this group was set at 37 JUg. of tissue to 2 ml. 
ot saline. Group III was identical to Group II except that the effects 
of chronically inflamed gingivae were measured instead of nomal gingivae. 
In Group IV the effects of normal gingival hanoganatea upon the enzyme t 
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substrate model were measured. The gingival specimens were obtained fraa 
subjects already included. in Group II. However, the concentration of the 
hmogenate solution was now increased by a factor of approximately two 
by increasing the weight of the specimen and adjusting the emomt of 
saline in the mixture. The results of Group V were obtained fran chron-
ical17 inflamed specimens of subjects included in Group lll. The homo-
genate concentration of the specimens was increased in the same manner lIB 
in Group IV. 
Although fiTe d1atinct group1l were delineated in Chapter lV, it will 
be necessary to correlate these groups to e~t the salient ideas de-
rived from this investigation. Initially, it would seem that the normal 
tissue spec:iJltens in group II had no effect upon the enss)'Jlle c~otrypain 
during the period of incubation. The spectrophotanetric readings o£ group 
m indicated a greater &momt of products of ~0lJ'81a in the homogenate 
enzyme substrate Ddxture as compared to the control group. Since these 
differences were statistically significant, an intrinsic proteolytic en-
ssyme with an action upon the substrate, casein, was present in the int'lam-
_tory tissue specimens of group III. 10 evidence of a possible ellQlU 
and enzyme inhibitor relationship can be shown lUltU the results of groups 
IV and V are simultaneously considered. 
Group IV samples demonstrated a significant inhibitory effect upon 
the elllS,.e c~oiiJ:7pel1n when they were compared to their "mates II in group 
n. This was true not only when the groups were considered as a whole 
and analyzed statistically but also when the "mated" samples were con ... 
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lidered individually between groups'. These results can be seen by can-
paring these groups in Table V. This same phenmenon was evident be-
tween groups III and V as shown in Table V. 
'1'0 what can "'these differences be attributed? 'l'he presence of an 
enzymatic inhibitor,- factor is definitely evident. '!'he enzyme inhibition 
can be detected after a change in concentration of the tissue samples. 
This may indicate that at the lower concentrations, the enzyme inhibitor 
effect or the tissue was not measurable by this method. However, by in-
creasing the concentration of the tissue homogenate the presence of an in-
hibitor could be dem.0n8trated in both n01'llal and inflamed tissue. Yet, 
this conclusion alone does not provide an adeq~te reason for the signifi-
cant differences between groups m and V. Group In demonstrated an in-
trinsic proteolytic activit,.. These data were Significantly different 
from group n as well as the control group, group I. When the concentra-
tion of the tissue homogenates was increased as in groups I'f and V, the 
inhibitor activity of both groups showed no Significant dUferenees. In 
fact, the differences in the levels of' proteolytic enz)'JIle activityof' 
normal and inflamed tissues were no longer apparent. This would sean to 
indicate a higher degree of inhibitor acti'Vity in inf'1amed tissues than 
in normal tusuea. 
On the other hand, the st'0d7 may be understood. more clearly by ex-
amining it from another aspect. 'the data from groups IV and V 1n<.iicate 
the presence of an inhibitor in both normal and chronically 1nf'1amed gin-
gival tissues. The fact that the normal. and inflamed tissues of groups 
II and III, which 'Here analyzed at a lower concentration" did not shaw 
the presence of an enzyme inhibitor can be attributed to a balanced re-
lationship of en!yme to inhibitor. This relationship between enzyme and 
inhibitor might not be numerically equivalent. That is" it might require 
more inhibitor to counteract a given amount of enzyme. In fact" this 
Beems to be true when the normal and pathological groups of lower tissue 
concentrations are considered in relation to the normal and pathologic 
groups of higher tissue concentraticn. If, for instance" a relationship 
of one part enzJ1l1le to two or more parts enz,.. inhibitor produced the zoe-
sruts of group II or III" then" by increasing the concentration of the 
tissue homogenate of the same subject, the net result would be one of ab-
solute enzyme inhibition. This is Ulustrated in the diagrams in figures 
.3 and 4. 
An in vivo interpretation of an enzyme I inhibitor mechanism of t.his 
--
nature is depicted in figure.3. Figure 4 depicts an a:na~1s of the 
.!!! .... v1;;..;tro;;;;..;;. situation as applied to this experiment. It can be seen that by 
keeping the amount of the e::lperimental enZ}'me, chymotrypsin" constant 
while varying the concentration of the tissue components" the abs olute 
inhibitor activity is altered. This alteration under experimental man-
ipulation would be depicted as an appearance of inhibitor activity. !his 
inhibitor activity would be approximated to the difference between the 
absolute inhibitor activity in vivo and the absolute inhibitor activity 
--
Therefore, a.na1.yzing the prabl_ in this manner" the results of 
groups II and IV becaae clearer. '!'hat is, in normal. gingival tissue a 
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balanced enzyme-antienzyme mechanism would shaw no effect upon the en-
zyme substrate mixture. Yet, the same tissue specimen at greater homo-
genate concentration would produce an inhibitory effect upon a similar 
enzyme substrate mixture. The results of groups m and V seem to in-
dicate tha:f:, an enzyme - inhibitor relationship would be a dynamic fiuc-
tuat1ng system just as 1t is true of 'Il18!W of the bodily" processes. In 
general the tissues in group III were fmmd to exert an additive pro-
teo1~rtic effect upon the en!lyme substrate mixture when compared to group 
I. Yet, upon increasing the tissue homogenate concentration, an inhibi-
tion ~:ras evident in amounts grea.t enough so that no significant differ-
ences be~Teen groups IV and V could be found. It will be remembered that 
the "mates" of these grours, groups II and TIl differed significantly. 
'!'hose find1ngs are a.ttributed to an overcompensation of the inl'.J.bitory 
.factors in response to the proteolytiC enzymes produced in the inflamma-
tory process. 
These ideas have basis iri the literature. West and Hilliard (1949) 
indicated that serum proteolytic inhibitor levels remainf'd elevated dur .. 
ing cert.91n disease states and when the tissues were undergoing an ad-
justment to a nonna.l state. 'fokuda (1959) showed that monocytes sub-
jected to an antigen-antibod.v res.ction secreted a protease and then a 
protease inhibitor. That latter work would seem to indicate the presence 
of a time relationship in that mechanism not only betlreen the proteases 
and the inhibitors that 'Were produced 1:'u.t aIao between cells or grr.ups 
of cells which "rere subj0cted to injury. In this ""aY nei.ther enz:YJlle nor 
-36-
inhibitor would act alone. Therefore, it is understandable that in a 
proteolytic enzyme and inhibitor mechanism. of' this type, a relationship 
such as the one described in this present study could produce the re-
sults that were obtained. 
Fran this investigation questions arise which must be answered by 
further research. 'l'he nature of the inhib1 tor must be determined. The 
de~ree to which the inhibitor,y factor measured in tissues is influenced 
by the proteolytic enzyme inhibitors in serum should be elucidated. Are 
results such as those obtained in groups II and IV of this study attrib-
utable to the fact that even so-called normal gingival tissues exbibit 
a chronic in.fl8lllnation to varying degrees? Only through a continuing 
quest for new ideas can lmowledge in any field progress. 
CHAPl'ER VI 
SUMMARY AND CONCImIONS 
'!'he purpose of this study lTaB to investigate the activity of pro-
teolytic enzymes in clinically and histologically normal gingival tis-
. sues as irell as chronically inflamed gingivae. The experimental pro-
cedures were designed to demonstrate any possible relationship of proteo-
lysis to proteolytic enzyme inhibition. Due to a minimum o:t information 
in the literature regarding a specific method of investigation.. the devel-
opment of such a method was considered important. 
Chapter III describes a method of investigation by which proteoly-
tic enzyme activity or proteolytic enzyme inhibition of a gingival tis-
sue specimen was measured. The procedure required homogenation of the 
tissue and incubation of the homogenate with a known Blllotmt of a pro-
teolytic enzyme. C~otrypsin l-ras used in this study. The mixture or 
enzyme and homogenate was then incuba:lied with a known quantity of sub-
strate for the enzyme. The products of hydrolysis were then measured 
colorimetrically after employing the Biuret reaction. byrne I sub-
strate control ~odels ~re employed as a basis for determining the pro-
teolytic or inhibitory activity of the tissue specimena. The method was 
'Workable using relatively small tissue samples. 
Ni..."18 normal gint';ival specimens and six chronicallY infla:a1led gin-
gival specimens from fifteen subjects w~re a.na.lyz.ed using the method 
described.. Significant dif.ferences were demonstrated between the 
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atteets of normal and inflamed R'ingivae upon the enz,me I substrate 
mixture. This was attributed to the proteolytic activity of the inflam-
matory proc€ss. The presence of an L"lhibitor of chymotrypsin loJaS demon-
strated in both noma1 and chronically inflamed hunum gi~ivae. '!'his wu 
accomplished by varying the concentration of the homogenate of tissue 
specimens from individual subjects. '!'he relationship bet.-reen an enzyme 
and its inhibitor, which could produce the results that are reported in 
Chapter '!V, nas discussed. 
The following conclusions seem to be justified on the basis of the 
res ults of this st~1 
1) '!'he method of investigation which t-taS developed is applicable 
to thia study. 
2) 'n'te presence of a proteo1J1tic enzl'Jlle inhibitor was demonstrated 
both in normal. and inflanted gingivae. 
3) '!'he tissues fran. 1n1'1amed ging1 va seem to have a. higher proteo-
lytic enzYMe 1nh1.bitor level than do corresponding samples freD 
normal ging1'ft. This conclusion is based on the observation 
that the additional proteolytie component ascribed to the hatlo-
genate sample is minimised or eliminated bY' elevating the tis-
sue homogenate level in the experimental procedure. Suoh a re-
versal in proteolytic behavior 'Was not demonstrable for the 
normal tissue homogenates. 
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